KONDENSIERTE PYRIDINE UND PYRIMIDINE MIT TIE2 (TEK) AKTIVITÄT

A compound of the Formula (I), wherein A together with the carbon atoms to which it is attached forms a fused 5-membered heteroaryl ring, wherein said heteroaryl ring contains 1 or 2 heteroatoms selected from O, N and S, and wherein the 5-membered ring containing G is linked to the ring formed by A...

Ausführliche Beschreibung

Gespeichert in:

Bibliographische Detailangaben
Hauptverfasser:	JONES, CLIFFORD DAVID, HAYTER, BARRY RAYMOND, MCCOULL, WILLIAM, LUKE, RICHARD WILLIAM ARTHUR
Format:	Patent
Sprache:	ger
Schlagworte:	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online-Zugang:	Volltext bestellen
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!

container_end_page
container_issue
container_start_page
container_title
container_volume
creator	JONES, CLIFFORD DAVID HAYTER, BARRY RAYMOND MCCOULL, WILLIAM LUKE, RICHARD WILLIAM ARTHUR
description	A compound of the Formula (I), wherein A together with the carbon atoms to which it is attached forms a fused 5-membered heteroaryl ring, wherein said heteroaryl ring contains 1 or 2 heteroatoms selected from O, N and S, and wherein the 5-membered ring containing G is linked to the ring formed by A in the meta position to the bridgehead carbon marked # in Formula (I): G is selected from O, S and NR5; Z is selected from N and CR6; Q1 is selected from optionally substituted aryl and heteroaryl, and the substituents R1 to R6 are as defined in the text for use in the production of an anti-angiogenic effect in a warm blooded animal such as man.
format	Patent
fullrecord	<record><control><sourceid>epo_EVB</sourceid><recordid>TN_cdi_epo_espacenet_ATE323702TT1</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>ATE323702TT1</sourcerecordid><originalsourceid>FETCH-epo_espacenet_ATE323702TT13</originalsourceid><addsrcrecordid>eNrjZLDz9vdzcfUL9nQNCnFVCIgM8nTx9HNVCPVzAXN8IVxfzxCFEE9XIwWNEFdvTQVH7xDPMM-Qwy0hPAysaYk5xam8UJqbQdHNNcTZQze1ID8-tbggMTk1L7Uk3jHE1djI2NzAKCTE0JgYNQCmDStD</addsrcrecordid><sourcetype>Open Access Repository</sourcetype><iscdi>true</iscdi><recordtype>patent</recordtype></control><display><type>patent</type><title>KONDENSIERTE PYRIDINE UND PYRIMIDINE MIT TIE2 (TEK) AKTIVITÄT</title><source>esp@cenet</source><creator>JONES, CLIFFORD DAVID ; HAYTER, BARRY RAYMOND ; MCCOULL, WILLIAM ; LUKE, RICHARD WILLIAM ARTHUR</creator><creatorcontrib>JONES, CLIFFORD DAVID ; HAYTER, BARRY RAYMOND ; MCCOULL, WILLIAM ; LUKE, RICHARD WILLIAM ARTHUR</creatorcontrib><description>A compound of the Formula (I), wherein A together with the carbon atoms to which it is attached forms a fused 5-membered heteroaryl ring, wherein said heteroaryl ring contains 1 or 2 heteroatoms selected from O, N and S, and wherein the 5-membered ring containing G is linked to the ring formed by A in the meta position to the bridgehead carbon marked # in Formula (I): G is selected from O, S and NR5; Z is selected from N and CR6; Q1 is selected from optionally substituted aryl and heteroaryl, and the substituents R1 to R6 are as defined in the text for use in the production of an anti-angiogenic effect in a warm blooded animal such as man.</description><edition>7</edition><language>ger</language><subject>CHEMISTRY ; HETEROCYCLIC COMPOUNDS ; HUMAN NECESSITIES ; HYGIENE ; MEDICAL OR VETERINARY SCIENCE ; METALLURGY ; ORGANIC CHEMISTRY ; PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES ; SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><creationdate>2006</creationdate><oa>free_for_read</oa><woscitedreferencessubscribed>false</woscitedreferencessubscribed></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktohtml>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060515&DB=EPODOC&CC=AT&NR=E323702T1$$EHTML$$P50$$Gepo$$Hfree_for_read</linktohtml><link.rule.ids>230,308,776,881,25542,76289</link.rule.ids><linktorsrc>$$Uhttps://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20060515&DB=EPODOC&CC=AT&NR=E323702T1$$EView_record_in_European_Patent_Office$$FView_record_in_$$GEuropean_Patent_Office$$Hfree_for_read</linktorsrc></links><search><creatorcontrib>JONES, CLIFFORD DAVID</creatorcontrib><creatorcontrib>HAYTER, BARRY RAYMOND</creatorcontrib><creatorcontrib>MCCOULL, WILLIAM</creatorcontrib><creatorcontrib>LUKE, RICHARD WILLIAM ARTHUR</creatorcontrib><title>KONDENSIERTE PYRIDINE UND PYRIMIDINE MIT TIE2 (TEK) AKTIVITÄT</title><description>A compound of the Formula (I), wherein A together with the carbon atoms to which it is attached forms a fused 5-membered heteroaryl ring, wherein said heteroaryl ring contains 1 or 2 heteroatoms selected from O, N and S, and wherein the 5-membered ring containing G is linked to the ring formed by A in the meta position to the bridgehead carbon marked # in Formula (I): G is selected from O, S and NR5; Z is selected from N and CR6; Q1 is selected from optionally substituted aryl and heteroaryl, and the substituents R1 to R6 are as defined in the text for use in the production of an anti-angiogenic effect in a warm blooded animal such as man.</description><subject>CHEMISTRY</subject><subject>HETEROCYCLIC COMPOUNDS</subject><subject>HUMAN NECESSITIES</subject><subject>HYGIENE</subject><subject>MEDICAL OR VETERINARY SCIENCE</subject><subject>METALLURGY</subject><subject>ORGANIC CHEMISTRY</subject><subject>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</subject><subject>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</subject><fulltext>true</fulltext><rsrctype>patent</rsrctype><creationdate>2006</creationdate><recordtype>patent</recordtype><sourceid>EVB</sourceid><recordid>eNrjZLDz9vdzcfUL9nQNCnFVCIgM8nTx9HNVCPVzAXN8IVxfzxCFEE9XIwWNEFdvTQVH7xDPMM-Qwy0hPAysaYk5xam8UJqbQdHNNcTZQze1ID8-tbggMTk1L7Uk3jHE1djI2NzAKCTE0JgYNQCmDStD</recordid><startdate>20060515</startdate><enddate>20060515</enddate><creator>JONES, CLIFFORD DAVID</creator><creator>HAYTER, BARRY RAYMOND</creator><creator>MCCOULL, WILLIAM</creator><creator>LUKE, RICHARD WILLIAM ARTHUR</creator><scope>EVB</scope></search><sort><creationdate>20060515</creationdate><title>KONDENSIERTE PYRIDINE UND PYRIMIDINE MIT TIE2 (TEK) AKTIVITÄT</title><author>JONES, CLIFFORD DAVID ; HAYTER, BARRY RAYMOND ; MCCOULL, WILLIAM ; LUKE, RICHARD WILLIAM ARTHUR</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-epo_espacenet_ATE323702TT13</frbrgroupid><rsrctype>patents</rsrctype><prefilter>patents</prefilter><language>ger</language><creationdate>2006</creationdate><topic>CHEMISTRY</topic><topic>HETEROCYCLIC COMPOUNDS</topic><topic>HUMAN NECESSITIES</topic><topic>HYGIENE</topic><topic>MEDICAL OR VETERINARY SCIENCE</topic><topic>METALLURGY</topic><topic>ORGANIC CHEMISTRY</topic><topic>PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES</topic><topic>SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS</topic><toplevel>online_resources</toplevel><creatorcontrib>JONES, CLIFFORD DAVID</creatorcontrib><creatorcontrib>HAYTER, BARRY RAYMOND</creatorcontrib><creatorcontrib>MCCOULL, WILLIAM</creatorcontrib><creatorcontrib>LUKE, RICHARD WILLIAM ARTHUR</creatorcontrib><collection>esp@cenet</collection></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext_linktorsrc</fulltext></delivery><addata><au>JONES, CLIFFORD DAVID</au><au>HAYTER, BARRY RAYMOND</au><au>MCCOULL, WILLIAM</au><au>LUKE, RICHARD WILLIAM ARTHUR</au><format>patent</format><genre>patent</genre><ristype>GEN</ristype><title>KONDENSIERTE PYRIDINE UND PYRIMIDINE MIT TIE2 (TEK) AKTIVITÄT</title><date>2006-05-15</date><risdate>2006</risdate><abstract>A compound of the Formula (I), wherein A together with the carbon atoms to which it is attached forms a fused 5-membered heteroaryl ring, wherein said heteroaryl ring contains 1 or 2 heteroatoms selected from O, N and S, and wherein the 5-membered ring containing G is linked to the ring formed by A in the meta position to the bridgehead carbon marked # in Formula (I): G is selected from O, S and NR5; Z is selected from N and CR6; Q1 is selected from optionally substituted aryl and heteroaryl, and the substituents R1 to R6 are as defined in the text for use in the production of an anti-angiogenic effect in a warm blooded animal such as man.</abstract><edition>7</edition><oa>free_for_read</oa></addata></record>
fulltext	fulltext_linktorsrc
identifier
ispartof
issn
language	ger
recordid	cdi_epo_espacenet_ATE323702TT1
source	esp@cenet
subjects	CHEMISTRY HETEROCYCLIC COMPOUNDS HUMAN NECESSITIES HYGIENE MEDICAL OR VETERINARY SCIENCE METALLURGY ORGANIC CHEMISTRY PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
title	KONDENSIERTE PYRIDINE UND PYRIMIDINE MIT TIE2 (TEK) AKTIVITÄT
url	https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-02-09T19%3A44%3A34IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-epo_EVB&rft_val_fmt=info:ofi/fmt:kev:mtx:patent&rft.genre=patent&rft.au=JONES,%20CLIFFORD%20DAVID&rft.date=2006-05-15&rft_id=info:doi/&rft_dat=%3Cepo_EVB%3EATE323702TT1%3C/epo_EVB%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_id=info:pmid/&rfr_iscdi=true